BPI
TWST icon

BFC Planning, Inc.’s Twist Bioscience TWST Stock Holding History

BFC Planning, Inc.’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823 Buy
+8
New +$521 ﹤0.01% 3182
2026
Q1 		– Sell
-7
Closed -$222 – 3327
2025
Q4 		$222 Hold
7
– – ﹤0.01% 3023
2025
Q3 		$197 Hold
7
– – ﹤0.01% 2821
2025
Q2 		$258 Buy
+7
New +$242 ﹤0.01% 2595

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EdgePoint Investment Group
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

BFC Planning, Inc.'s TWST Position: Q2 2026 in Review

BFC Planning, Inc. opened a new position in Twist Bioscience (TWST) in Q2 2026: 8 shares worth $823. The stake represents ﹤0.01% of the portfolio and ranks #3182 among its holdings. This is a return to the name: BFC Planning, Inc. previously reported a position in TWST as recently as Q4 2025.

BFC Planning, Inc. first reported a position in TWST in Q2 2025 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • BFC Planning, Inc. held 8 shares of Twist Bioscience worth $823 as of Q2 2026.
  • Twist Bioscience was a new BFC Planning, Inc. position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3182 holding.
  • BFC Planning, Inc. first reported a position in Twist Bioscience in Q2 2025 and has held it in 4 quarters since.
  • 339 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.